mRNA治療薬の市場規模、シェア、成長分析：タイプ別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

mRNA治療薬市場規模は2023年に110億米ドルと評価され、予測期間（2025-2032年）のCAGRは6.5%で、2024年の117億1,000万米ドルから2032年には193億9,000万米ドルに成長する見通しです。

mRNA治療薬市場は、特に慢性疾患の治療において、主にModernaとPfizer-BioNTechによるCOVID-19パンデミック時のmRNAワクチンの展開成功に牽引され、大きな成長を遂げています。これらのワクチンは、その安全性と製造・流通の効率性から、DNAワクチンよりも好まれるようになってきています。ヒト臨床試験での成功により需要が高まり、特にがん領域では、がんmRNAワクチンの臨床試験がボランティアの大きな関心を集めました。新たなSARS-CoV-2亜種が出現するにつれ、効果的なmRNAソリューションの必要性はより緊急性を増しています。技術の進歩はmRNA製品の安定性と送達を向上させ、個別化医療を変革し、ヘルスケアの標準を再構築し、市場拡大に拍車をかけるこの分野の将来性を示唆しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制分析
• 特許分析

mRNA治療薬市場規模：タイプ別& CAGR（2025-2032）

• 市場概要
• 予防
• 治療

mRNA治療薬市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 感染症
• 腫瘍
• 稀な遺伝性疾患
• 呼吸器疾患
• その他

mRNA治療薬市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 病院・クリニック
• 調査機関
• その他

mRNA治療薬市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Lonza Group（Switzerland）
• Samsung Biologics（South Korea）
• Fujifilm Diosynth Biotechnologies（Japan）
• Catalent（United States）
• BioNTech（Germany）
• Ionis Pharmaceuticals（United States）
• WuXi Biologics（China）
• CordenPharma（Germany）
• WuXi AppTec（China）
• Boehringer Ingelheim（Germany）
• Samsung Biologics（South Korea）
• WuXi Biologics（China）
• WuXi AppTec（China）
• Boehringer Ingelheim（Germany）
• WuXi Biologics（China）
• WuXi AppTec（China）
• Boehringer Ingelheim（Germany）
• WuXi Biologics（China）
• WuXi AppTec（China）
• Boehringer Ingelheim（Germany）

結論と提言

mRNA Therapeutics Market size was valued at USD 11.0 billion in 2023 and is poised to grow from USD 11.71 billion in 2024 to USD 19.39 billion by 2032, growing at a CAGR of 6.5% during the forecast period (2025-2032).

The mRNA therapeutics market has experienced significant growth, particularly in treating chronic conditions, driven by the successful deployment of mRNA vaccines during the COVID-19 pandemic, primarily by Moderna and Pfizer-BioNTech. These vaccines are increasingly preferred over DNA alternatives due to their safety and efficiency in production and distribution. Their success in human clinical trials has heightened demand, particularly in oncology, where cancer mRNA vaccine trials garnered substantial volunteer interest. As new SARS-CoV-2 variants emerge, the need for effective mRNA solutions becomes more urgent. Advancements in technology are enhancing mRNA product stability and delivery, suggesting a promising future for this sector, which is set to transform personalized medicine and reshape healthcare standards, further fueling market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Mrna Therapeutics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Mrna Therapeutics Market Segments Analysis

Global mRNA Therapeutics Market is segmented by Type, Application, End-user and region. Based on Type, the market is segmented into Prophylactic and Therapeutic. Based on Application, the market is segmented into Infectious Diseases, Oncology, Rare Genetic Diseases,respiratory diseasesand Others. Based on End-user, the market is segmented into Hospitals & Clinics, Research Organizations and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Mrna Therapeutics Market

The rapid advancement of mRNA vaccine technology during the COVID-19 pandemic has significantly propelled the mRNA therapeutics market. This health crisis highlighted mRNA's efficacy as a robust mechanism for addressing infectious diseases, paving the way for its broader application in therapeutics. As a result, mRNA has emerged not only as a crucial defense against viruses but also as a promising platform for developing treatments for various diseases, including cancer and genetic disorders. The momentum gained from pandemic-related research and development is expected to continue driving innovation and investment in the mRNA therapeutics sector, solidifying its position in modern medicine.

Restraints in the Mrna Therapeutics Market

The global mRNA therapeutics market faces several constraints, particularly regarding its production and distribution processes. One significant challenge is the need to scale up mRNA production capacity while ensuring a reliable supply chain. This has been particularly problematic during instances like a global health pandemic, which exacerbates the difficulties of maintaining consistent production levels and distribution efficiency. The complexities of establishing and optimizing these processes hinder market growth and innovation, underscoring the need for improved infrastructure and strategic planning within the mRNA therapeutics landscape to effectively meet increasing demand and overcome logistical challenges.

Market Trends of the Mrna Therapeutics Market

The mRNA therapeutics market is witnessing a significant upward trend, particularly in the development of mRNA cancer vaccines, which offer promising advancements in oncology treatment. As research in this field evolves, pharmaceutical companies are increasingly investing in mRNA technology to create tailored vaccines that stimulate the immune system to target specific cancer cells. This innovation not only enhances the potential for personalized medicine but also showcases the adaptability of mRNA platforms beyond infectious diseases, drawing attention from investors and stakeholders alike. Consequently, the mRNA cancer vaccine segment is poised for substantial growth, driving breakthroughs in cancer therapy and ultimately transforming patient outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Patent Analysis

Global mRNA Therapeutics Market Size by Type & CAGR (2025-2032)

• Market Overview
• Prophylactic
• Therapeutic

Global mRNA Therapeutics Market Size by Application & CAGR (2025-2032)

• Market Overview
• Infectious Diseases
• Oncology
• Rare Genetic Diseases
• Respiratory Diseases
• Others

Global mRNA Therapeutics Market Size by End-user & CAGR (2025-2032)

• Market Overview
• Hospitals & Clinics
• Research Organizations
• Others

Global mRNA Therapeutics Market Size & CAGR (2025-2032)

• North America (Type, Application, End-user)
  • US
  • Canada
• Europe (Type, Application, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Application, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Application, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Application, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Lonza Group (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Samsung Biologics (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Diosynth Biotechnologies (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Catalent (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioNTech (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ionis Pharmaceuticals (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi Biologics (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CordenPharma (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Samsung Biologics (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi Biologics (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi Biologics (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi Biologics (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations